Discuss This Drug

brexanolone

CHEBI:CHEBI_746942

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2121786
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
dea_schedule
CIV
active_ingredient_strength
1 kg/kg
route
INTRAVENOUS
pharm_class_moa
GABA A Receptor Positive Modulators [MoA]
pharm_class
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
marketing_start_date
20210217
package_marketing_start_date
17-FEB-21
generic_name
Brexanolone
brand_name
Zulresso
brand_name_base
Zulresso
product_ndc
65089-0060
application_number
NDA211371
labeler_name
Curia Spain S.A.U.
manufacturer_name
Sage Therapeutics, Inc.
spl_id
ccaa6800-ce90-080d-e053-2995a90a724e
active_ingredient_name
BREXANOLONE
package_ndc
65089-0060-1
package_description
1 kg in 1 DRUM (65089-0060-1)
unii
S39XZ5QV8Y
spl_set_id
b40f3b2a-1859-4ed6-8551-444300806d13
nui
N0000193997
upc
0372152547208
pharm_class_epc
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class